Global Intravenous-to-Subcutaneous Drug Market Professional Survey Report 2017

October 2017 | 101 pages | ID: G0E6405874EPEN
QYResearch

Abstracts

This report studies Intravenous-to-Subcutaneous Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Novartis
• GSK
• Merck

By types, the market can be split into

• Prescription
• OCT

By Application, the market can be split into

• Hospital
• Medical Center

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Intravenous-to-Subcutaneous Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF INTRAVENOUS-TO-SUBCUTANEOUS DRUG

1.1 Definition and Specifications of Intravenous-to-Subcutaneous Drug
  1.1.1 Definition of Intravenous-to-Subcutaneous Drug
  1.1.2 Specifications of Intravenous-to-Subcutaneous Drug
1.2 Classification of Intravenous-to-Subcutaneous Drug
  1.2.1 Prescription
  1.2.2 OCT
1.3 Applications of Intravenous-to-Subcutaneous Drug
  1.3.1 Hospital
  1.3.2 Medical Center
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF INTRAVENOUS-TO-SUBCUTANEOUS DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Intravenous-to-Subcutaneous Drug
2.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
2.4 Industry Chain Structure of Intravenous-to-Subcutaneous Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF INTRAVENOUS-TO-SUBCUTANEOUS DRUG

3.1 Capacity and Commercial Production Date of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016

4 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Intravenous-to-Subcutaneous Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Intravenous-to-Subcutaneous Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Intravenous-to-Subcutaneous Drug Sales and Growth Rate Analysis
  4.3.2 2016 Intravenous-to-Subcutaneous Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Intravenous-to-Subcutaneous Drug Sales Price
  4.4.2 2016 Intravenous-to-Subcutaneous Drug Sales Price Analysis (Company Segment)

5 INTRAVENOUS-TO-SUBCUTANEOUS DRUG REGIONAL MARKET ANALYSIS

5.1 North America Intravenous-to-Subcutaneous Drug Market Analysis
  5.1.1 North America Intravenous-to-Subcutaneous Drug Market Overview
  5.1.2 North America 2012-2017E Intravenous-to-Subcutaneous Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price Analysis
  5.1.4 North America 2016 Intravenous-to-Subcutaneous Drug Market Share Analysis
5.2 China Intravenous-to-Subcutaneous Drug Market Analysis
  5.2.1 China Intravenous-to-Subcutaneous Drug Market Overview
  5.2.2 China 2012-2017E Intravenous-to-Subcutaneous Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price Analysis
  5.2.4 China 2016 Intravenous-to-Subcutaneous Drug Market Share Analysis
5.3 Europe Intravenous-to-Subcutaneous Drug Market Analysis
  5.3.1 Europe Intravenous-to-Subcutaneous Drug Market Overview
  5.3.2 Europe 2012-2017E Intravenous-to-Subcutaneous Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price Analysis
  5.3.4 Europe 2016 Intravenous-to-Subcutaneous Drug Market Share Analysis
5.4 Southeast Asia Intravenous-to-Subcutaneous Drug Market Analysis
  5.4.1 Southeast Asia Intravenous-to-Subcutaneous Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Intravenous-to-Subcutaneous Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Intravenous-to-Subcutaneous Drug Market Share Analysis
5.5 Japan Intravenous-to-Subcutaneous Drug Market Analysis
  5.5.1 Japan Intravenous-to-Subcutaneous Drug Market Overview
  5.5.2 Japan 2012-2017E Intravenous-to-Subcutaneous Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price Analysis
  5.5.4 Japan 2016 Intravenous-to-Subcutaneous Drug Market Share Analysis
5.6 India Intravenous-to-Subcutaneous Drug Market Analysis
  5.6.1 India Intravenous-to-Subcutaneous Drug Market Overview
  5.6.2 India 2012-2017E Intravenous-to-Subcutaneous Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price Analysis
  5.6.4 India 2016 Intravenous-to-Subcutaneous Drug Market Share Analysis

6 GLOBAL 2012-2017E INTRAVENOUS-TO-SUBCUTANEOUS DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Intravenous-to-Subcutaneous Drug Sales by Type
6.2 Different Types of Intravenous-to-Subcutaneous Drug Product Interview Price Analysis
6.3 Different Types of Intravenous-to-Subcutaneous Drug Product Driving Factors Analysis
  6.3.1 Prescription of Intravenous-to-Subcutaneous Drug Growth Driving Factor Analysis
  6.3.2 OCT of Intravenous-to-Subcutaneous Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E INTRAVENOUS-TO-SUBCUTANEOUS DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Intravenous-to-Subcutaneous Drug Consumption by Application
7.2 Different Application of Intravenous-to-Subcutaneous Drug Product Interview Price Analysis
7.3 Different Application of Intravenous-to-Subcutaneous Drug Product Driving Factors Analysis
  7.3.1 Hospital of Intravenous-to-Subcutaneous Drug Growth Driving Factor Analysis
  7.3.2 Medical Center of Intravenous-to-Subcutaneous Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF INTRAVENOUS-TO-SUBCUTANEOUS DRUG

8.1 Novartis
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Novartis 2016 Intravenous-to-Subcutaneous Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novartis 2016 Intravenous-to-Subcutaneous Drug Business Region Distribution Analysis
8.2 GSK
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 GSK 2016 Intravenous-to-Subcutaneous Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 GSK 2016 Intravenous-to-Subcutaneous Drug Business Region Distribution Analysis
8.3 Merck
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Merck 2016 Intravenous-to-Subcutaneous Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Merck 2016 Intravenous-to-Subcutaneous Drug Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF INTRAVENOUS-TO-SUBCUTANEOUS DRUG MARKET

9.1 Global Intravenous-to-Subcutaneous Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Intravenous-to-Subcutaneous Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Intravenous-to-Subcutaneous Drug Sales Price Forecast
9.2 Intravenous-to-Subcutaneous Drug Regional Market Trend
  9.2.1 North America 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Forecast
  9.2.2 China 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Forecast
  9.2.6 India 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Forecast
9.3 Intravenous-to-Subcutaneous Drug Market Trend (Product Type)
9.4 Intravenous-to-Subcutaneous Drug Market Trend (Application)

10 INTRAVENOUS-TO-SUBCUTANEOUS DRUG MARKETING TYPE ANALYSIS

10.1 Intravenous-to-Subcutaneous Drug Regional Marketing Type Analysis
10.2 Intravenous-to-Subcutaneous Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Intravenous-to-Subcutaneous Drug by Region
10.4 Intravenous-to-Subcutaneous Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF INTRAVENOUS-TO-SUBCUTANEOUS DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Intravenous-to-Subcutaneous Drug
Table Product Specifications of Intravenous-to-Subcutaneous Drug
Table Classification of Intravenous-to-Subcutaneous Drug
Figure Global Production Market Share of Intravenous-to-Subcutaneous Drug by Type in 2016
Figure Prescription Picture
Table Major Manufacturers of Prescription
Figure OCT Picture
Table Major Manufacturers of OCT
Table Applications of Intravenous-to-Subcutaneous Drug
Figure Global Consumption Volume Market Share of Intravenous-to-Subcutaneous Drug by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Medical Center Examples
Table Major Consumers in Medical Center
Figure Market Share of Intravenous-to-Subcutaneous Drug by Regions
Figure North America Intravenous-to-Subcutaneous Drug Market Size (Million USD) (2012-2022)
Figure China Intravenous-to-Subcutaneous Drug Market Size (Million USD) (2012-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Market Size (Million USD) (2012-2022)
Figure Japan Intravenous-to-Subcutaneous Drug Market Size (Million USD) (2012-2022)
Figure India Intravenous-to-Subcutaneous Drug Market Size (Million USD) (2012-2022)
Table Intravenous-to-Subcutaneous Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Intravenous-to-Subcutaneous Drug in 2016
Figure Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
Figure Industry Chain Structure of Intravenous-to-Subcutaneous Drug
Table Capacity and Commercial Production Date of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Intravenous-to-Subcutaneous Drug 2012-2017
Figure Global 2012-2017E Intravenous-to-Subcutaneous Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Intravenous-to-Subcutaneous Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Intravenous-to-Subcutaneous Drug Capacity and Growth Rate
Table 2016 Global Intravenous-to-Subcutaneous Drug Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate
Table 2016 Global Intravenous-to-Subcutaneous Drug Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs)
Table 2016 Global Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Intravenous-to-Subcutaneous Drug 2012-2017E
Figure North America 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs)
Figure North America 2016 Intravenous-to-Subcutaneous Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Intravenous-to-Subcutaneous Drug 2012-2017E
Figure China 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs)
Figure China 2016 Intravenous-to-Subcutaneous Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Intravenous-to-Subcutaneous Drug 2012-2017E
Figure Europe 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs)
Figure Europe 2016 Intravenous-to-Subcutaneous Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Intravenous-to-Subcutaneous Drug 2012-2017E
Figure Southeast Asia 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Intravenous-to-Subcutaneous Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Intravenous-to-Subcutaneous Drug 2012-2017E
Figure Japan 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs)
Figure Japan 2016 Intravenous-to-Subcutaneous Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Intravenous-to-Subcutaneous Drug 2012-2017E
Figure India 2012-2017E Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs)
Figure India 2016 Intravenous-to-Subcutaneous Drug Sales Market Share
Table Global 2012-2017E Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Type
Table Different Types Intravenous-to-Subcutaneous Drug Product Interview Price
Table Global 2012-2017E Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Application
Table Different Application Intravenous-to-Subcutaneous Drug Product Interview Price
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Intravenous-to-Subcutaneous Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis Intravenous-to-Subcutaneous Drug Business Region Distribution
Table GSK Information List
Table Product A Overview
Table Product B Overview
Table 2016 GSK Intravenous-to-Subcutaneous Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GSK Intravenous-to-Subcutaneous Drug Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2015 Merck Intravenous-to-Subcutaneous Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck Intravenous-to-Subcutaneous Drug Business Region Distribution
Figure Global 2017-2022 Intravenous-to-Subcutaneous Drug Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Intravenous-to-Subcutaneous Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Intravenous-to-Subcutaneous Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Intravenous-to-Subcutaneous Drug by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Intravenous-to-Subcutaneous Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Intravenous-to-Subcutaneous Drug by Region